Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study

BACKGROUND: In October 2012, the Chinese government established maximum retail prices for specific products, including 30 antineoplastic medications. Three years later, in June 2015, the government abolished price regulation for most medications, including all antineoplastic medications. This study...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Main Authors: Guan, Xiaodong, Wushouer, Haishaerjiang, Yang, Mingchun, Han, Sheng, Shi, Luwen, Ross-Degnan, Dennis, Wagner, Anita Katharina
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2019
Assuntos:
Health Policy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6924745/
https://ncbi.nlm.nih.gov/pubmed/31784440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031658
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares